千红制药员工持股计划完成过户 可转债申请获受理

Group 1 - The company has made progress in governance and financing, completing the non-trading transfer of 12 million shares at a price of 4.53 yuan per share, which accounts for 0.94% of the total share capital, with a duration of no more than 48 months and unlocking in two phases [1] - The company has received acceptance from the Shenzhen Stock Exchange for its application to issue convertible bonds to unspecified objects, and related work is progressing in an orderly manner [1] Group 2 - The stock price of the company has shown slight fluctuations, with a decrease of 0.38% from the closing price of 7.86 yuan on February 5 to 7.83 yuan on February 12, with a trading range of 2.42% [2] - The highest stock price during this period was 8.01 yuan on February 10, while the lowest was 7.82 yuan on February 12 [2] - The trading volume peaked at a turnover rate of 1.48% on February 6, but decreased to 0.59% on February 12, with a transaction amount shrinking to 43.49 million yuan [2] - The stock price is currently below the 20-day moving average of 8.02 yuan, and the MACD indicator shows a weak consolidation trend [2]